Financials
Financial year 2025
Dr. Sander Vandaele, Radiotherapie-Oncologie from Temse, company number BE1028064594, closed financial year 2025 with a result of € 9,825 after tax. For that financial year Dr. Sander Vandaele, Radiotherapie-Oncologie recorded a gross margin of € 17,128 and equity of € 19,825. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 19,825
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,825
Profit after tax over the fiscal year.
€ 14,670
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 9,825.
People and assets in 2025
€ 32,242
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 33,928
€ 6,561 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 235
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Dr. Sander Vandaele, Radiotherapie-Oncologie?
What happened at Dr. Sander Vandaele, Radiotherapie-Oncologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 9,825. Source: NBB ↗
- New establishment in Temse. KBO
- Start of the company according to the CBE. KBO
In short
Paid € 3,183 in corporate taxes since 2025.
A new publication or filing at Dr. Sander Vandaele, Radiotherapie-Oncologie? We notify you, reason included.
Follow Dr. Sander Vandaele, Radiotherapie-OncologieDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Kasteeldreef 16
9140 Temse
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1028.064.594
- VAT number
- BE 1028.064.594
- Registered office
- Kasteeldreef 16, 9140 Temse
- Names & denominations
- Dr. Sander Vandaele, Radiotherapie-Oncologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 September 2025
- Peppol
- Active · Active since 15 Oct 2025
- Activities · NACE
Activiteiten van medisch specialisten